| 1 |
|
Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment/
|
Yarovoi, H. V
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2 |
|
Factor XI inhibitors/
|
Gailani, D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 3 |
|
Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems/
|
Gordon, S. M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 4 |
|
Fanconi anemia stem cells: going round and round/
|
Carreau, M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 5 |
|
Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis/
|
Freie, B
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 6 |
|
Farnesyltransferase inhibitors in hematologic malignancies: new horizons in therapy/
|
Lancet, J. E
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 7 |
|
Fatal hepatic necrosis following imatinib mesylate therapy/
|
Lin, N. U
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 8 |
|
Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy/
|
Westhoff, T. H
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 9 |
|
Fcgamma receptor transmembrane domains: role in cell surface expression, gamma chain interaction, and phagocytosis/
|
Kim, M.-K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 10 |
|
Fetal microchimerism-what our children leave behind/
|
Verneris, M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 11 |
|
Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure/
|
Cooper, A. V
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 12 |
|
Fibrinogen is necessary for platelet function in vivo after all/
|
Bennett, J. S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 13 |
|
Fighting HIV: a little help from Toxoplasma?/
|
Lusso, P
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 14 |
|
Filamin A binding to the cytoplasmic tail of glycoprotein Ibalpha regulates von Willebrand factor-induced platelet activation/
|
Feng, S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 15 |
|
Flexible migration program regulates gammadelta T-cell involvement in humoral immunity/
|
Brandes, M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 16 |
|
FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress/
|
Libura, M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 17 |
|
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance/
|
Zwaan, C. M
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 18 |
|
Fludarabine plus rituximab for untreated B-cell chronic lymphocytic leukemia/
|
Castagna, L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 19 |
|
Fluorescence measurements of the labile iron pool of sickle erythrocytes/
|
Darbari, D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 20 |
|
Formation of trisomies and their parental origin in hyperdiploid childhood acute lymphoblastic leukemia/
|
Paulsson, K
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|